TRACON PHARMACEUTICALS INC (TCON)
US89237H3084 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.59M | -29.14M | -28.67M | -16.78M | -22.67M | |||
| Depreciation Amortization | 14.00K | 20.00K | 10.00K | 10.00K | 20.00K | |||
| Change In Working Capital | -2.15M | -240.00K | 4.55M | -1.45M | -2.88M | |||
| Interest Paid | 7.49M | 360.00K | 270.00K | 440.00K | 610.00K | |||
| Other non cash items | 9.40M | 3.12M | 1.54M | 1.17M | 1.88M | |||
| OPERATING CASH FLOW | 3.68M | -26.24M | -22.57M | -17.04M | -23.65M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 0.00 | -20.00K | -50.00K | -10.00K | 0.00 | |||
| Other Investing Activity | 0.00 | 0.00 | 4.00M | -4.00M | 14.02M | |||
| INVESTING CASH FLOW | 0.00 | -20.00K | 3.95M | -4.00M | 14.02M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -20.50M | 8.28M | -2.80M | -1.40M | -1.40M | |||
| Stock Issued/Repurchased | 7.96M | 7.97M | 13.36M | 38.16M | 2.33M | |||
| Other Financing Activity | N/A | 3.43M | N/A | N/A | -20.00K | |||
| FINANCING CASH FLOW | -12.54M | 19.68M | 10.56M | 36.76M | 910.00K | |||
| CHANGE IN CASH | -8.86M | -6.58M | -8.06M | 15.72M | -8.72M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 3.68M | -26.24M | -22.57M | -17.04M | -23.65M | |||
| Capital Expenditure | 0.00 | -20.00K | -50.00K | -10.00K | 0.00 | |||
| FREE CASH FLOW | 3.68M | -26.26M | -22.62M | -17.05M | -23.65M | |||
All data in USD